Frequently Asked Question:
COVID-19 has declined non-essential medical facilities services, declining the market.
North America accounted for the most heightened share in the global microbiome therapeutics market.
development of microbiome technology in the healthcare sector
The FMT segment had a major global market share in 2022
The diabetes segment had a major share in the global market